PCSK9 Forum
Facebook Twitter RSS
For latest updates
Register today
Home About PCSK9 Forum News Expert Opinion Education & Resources Register

Welcome to the PCSK9 Education and Research Forum

On behalf of the Executive Editorial Board and our Editorial Advisory Board we would like to thank you for becoming a member of this new initiative in the prevention of atherosclerosis and cardiovascular disease, the PCSK9 Education and Research Forum.

We are delighted that you have joined us and colleagues around the world in fostering education and research focussed on the importance of PCSK9 in lipid and cholesterol metabolism as well as its value as a novel therapeutic target.

Significant resources already available

On our website you will already find a wide spectrum of valuable resources including educational programmes, reviews, videos and slides incorporating the latest research.  These resources are being continuously updated as new information becomes available.

We look forward to sharing these programmes with you and receiving your feedback.

Your contribution to the Forum is welcome

One of the Forum’s key objectives is to promote the sharing of information and ideas. Therefore, we hope that you will also contribute by submitting resources, articles and information for publication on the site.

Please send any contributions and feedback to the Secretariat who will circulate it to the editors.

Please invite colleagues to join us

We would also like to ask you to invite colleagues who are interested in this rapidly emerging field of research to join the Forum.

As you know membership is free and registration is easy on the PCSK9 Forum website.

Thank you again for joining the Forum which we hope will make a valuable and important contribution to this exciting new area of cardiovascular research.

With best regards


M John Chapman, PhD, DSc, FESC
Editor, PCSK9 Education and Research Forum

Research Professor, University of Pierre and Marie Curie,
Director Emeritus, INSERM,
Past-President, European Atherosclerosis Society,
Pitie-Salpetriere University Hospital,
Paris, France

  Henry N. Ginsberg, MD
Editor, PCSK9 Education and Research Forum

Irving Professor of Medicine
Director, Irving Institute for Clinical and Translational Research
College of Physicians and Surgeons
Columbia University, New York
About PCSK9 Education and Research Forum

Watch the Aims & Objectives video
Read our Mission Statement
Partnership and outreach
Meet our Editorial Board
View Forthcoming Meetings

Video: Prof Kosh Ray, UK: Residual cardiovascular risk – a role for PCSK9 inhibition
Video: Dr Dirk Blom, South Africa: FH issues in low to middle income regions
Video: Dr Dirk Blom, South Africa: The role of PCSK9 inhibitors in FH

Read more news »
Hot topics

Video: Lowering LDL-C: How low and for how long?
Dr Evan Stein
Video: LDL-C: how low should clinicians aim for?
Prof Henry Ginsberg

FH Challenges: Improving FH detection in primary care: a UK audit tool

Opportunities for personalised medicine in FH? Marina Cuchel

The FH enigma: are there other FH-causing genes? A genetic diagnosis is established in about 80% of patients with FH.

  Supported by educational grants from: Amgen Lilly pFizer Sanofi  
Copyright PCSK9 Forum 2014. Please click here to unsubscribe from future mailings.